The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy
Open accessAbstract
Diabetes causes metabolic and physiologic abnormalities in the retina, and these changes suggest a role for inflammation in the development of diabetic retinopathy. These changes include upregulation of iNOS, COX‐2, ICAM‐1, caspase 1, VEGF, and NF‐κ B, increased production of nitric oxide, prostaglandin E2, IL‐1 β, and cytokines, as well as increased permeability and leukostasis. Using selective pharmacologic inhibitors or genetically modified animals, an increasing number of therapeutic approaches have been identified that significantly inhibit development of at least the early stages of diabetic retinopathy, especially occlusion and degeneration of retinal capillaries. A common feature of a number of these therapies is that they inhibit production of inflammatory mediators. The concept that localized inflammatory processes play a role in the development of diabetic retinopathy is relatively new, but evidence that supports the hypothesis is accumulating rapidly. This new hypothesis offers new insight into the pathogenesis of diabetic retinopathy, and offers novel targets to inhibit the ocular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Self-citationAminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,051
Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,038
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., & Currie, M. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90357-n · Cited by 721
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades
Hubbard, A. K., & Rothlein, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00223-9 · Cited by 594
Antonetti, D. A., Barber, A. J., Khin, S., Lieth, E., Tarbell, J. M., & Gardner, T. W. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1953 · Cited by 577
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567
Krady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., & Levison, S. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1559 · Cited by 529
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzstefanou, K., Ferrara, N., & Adamis, A. P. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30420-x · Cited by 518
Glial reactivity, an early feature of diabetic retinopathy.
Rungger‐Brändle, E., Dosso, A., & Leuenberger, P. (2000) · PubMed · Cited by 509
Gamble, J. R., Drew, J., Trezise, L., Underwood, A., Parsons, M., Kasminkas, L., Rudge, J., Yancopoulos, G., & Vadas, M. A. (2000) · Circulation Research · doi:10.1161/01.res.87.7.603 · Cited by 505
Müller cell changes in human diabetic retinopathy.
Mizutani, M., Gerhardinger, C., & Lorenzi, M. (1998) · Diabetes · doi:10.2337/diabetes.47.3.445 · Cited by 481
Schröder, S., Palinski, W., & Schmid‐Schönbein, G. W. (1991) · PubMed Central · Cited by 479
A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P. R., Patel, R. N., Patel, I. R., & Abramson, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14014 · Cited by 474
The Ins2AkitaMouse as a Model of Early Retinal Complications in Diabetes
Barber, A. J., Antonetti, D. A., Kern, T. S., Reiter, C. E. N., Soans, R. S., Krady, J. K., Levison, S. W., Gardner, T. W., & Bronson, S. K. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1340 · Cited by 472
Self-citationLieth, E., Barber, A. J., Xu, B., Dice, C., Ratz, M. J., Tanase, D., & Strother, J. M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.815 · Cited by 467
Death of Retinal Neurons in Streptozotocin-Induced Diabetic Mice
Martin, P. M., Roon, P., Van Ells, T. K., Ganapathy, V., & Smith, S. B. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0247 · Cited by 453
Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia
Kowluru, R. A., Tang, J., & Kern, T. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1938 · Cited by 435
Self-citationRomeo, G., Liu, W.-H., Asnaghi, V., Kern, T. S., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2241 · Cited by 412
Self-citationDemircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
Quagliarello, V. J., Wispelwey, B., Long, W. J., & Scheld, W. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115140 · Cited by 372
Risk Factors Associated with the Incidence of Open-Angle Glaucoma: The Visual Impairment Project
Le, A., Mukesh, B. N., McCarty, C. A., & Taylor, H. R. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0077 · Cited by 370
Retinal neurodegeneration: early pathology in diabetes
Lieth, E., Gardner, T. W., Barber, A. J., & Antonetti, D. A. (2000) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00222.x · Cited by 360
Barber, A. J., Antonetti, D. A., & Gardner, T. W. (2000) · PubMed · Cited by 353
Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema
Arevalo, J. F., Fromow-Guerra, J., Quiroz-Mercado, H., Sanchez, J. G., Wu, L., Maia, M., Berrocal, M. H., Solis-Vivanco, A., & Farah, M. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.028 · Cited by 335
Miyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L. P., Ogura, Y., & Adamis, A. P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65044-4 · Cited by 332
Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina
Park, S.-H., Park, J.-W., Park, S.-J., Kim, K.-Y., Chung, J.-W., Chun, M.-H., & Oh, S.-J. (2003) · Diabetologia · doi:10.1007/s00125-003-1177-6 · Cited by 322
Vincent, J. A., & Mohr, S. (2007) · Diabetes · doi:10.2337/db06-0427 · Cited by 298
Doganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Kowluru, R. A., Koppolu, P., Chakrabarti, S., & Chen, S. (2003) · Free Radical Research · doi:10.1080/10715760310001604189 · Cited by 289
Microglia provide neuroprotection after ischemia
Neumann, J., Gunzer, M., Gutzeit, H. O., Ullrich, O., Reymann, K. G., & Dinkel, K. (2006) · The FASEB Journal · doi:10.1096/fj.05-4882fje · Cited by 287
Kowluru, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.818 · Cited by 282
Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes
Feit-Leichman, R. A., Kinouchi, R., Takeda, M., Fan, Z., Mohr, S., Kern, T. S., & Chen, D. F. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1361 · Cited by 281
Self-citationNeuronal and microglial response in the retina of streptozotocin-induced diabetic rats
ZENG, X.-X., NG, Y.-K., & LING, E.-A. (2000) · Visual Neuroscience · doi:10.1017/s0952523800173122 · Cited by 280
Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., & Lorenzi, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.506 · Cited by 279
Pharmacological Inhibition of Diabetic Retinopathy
Kern, T. S., & Engerman, R. L. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1636 · Cited by 277
Self-citationNeuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N.-T., Caldwell, R. B., & Liou, G. I. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050500 · Cited by 274
Antonetti, D. A., Wolpert, E. B., DeMaio, L., Harhaj, N. S., & Scaduto, R. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00740.x · Cited by 272
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)
JORGE, R., COSTA, R. A., CALUCCI, D., CINTRA, L. P., & SCOTT, I. U. (2006) · Retina · doi:10.1097/01.iae.0000246884.76018.63 · Cited by 258
Kern, T. S., Tang, J., Mizutani, M., Kowluru, A., Nagaraj, R. H., Romeo, G. R., Podestà, F., & Lorenzi, M. (2000) · PubMed · Cited by 253
Self-citationTamura, H., Miyamoto, K., Kiryu, J., Miyahara, S., Katsuta, H., Hirose, F., Musashi, K., & Yoshimura, N. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0905 · Cited by 251
Tolentino, M. J., Mcleod, D. S., Taomoto, M., Otsuji, T., Adamis, A. P., & Lutty, G. A. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01381-2 · Cited by 250
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy
Yuuki, T., Kanda, T., Kimura, Y., Kotajima, N., Tamura, J., Kobayashi, I., & Kishi, S. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00155-6 · Cited by 248
Hammes, H.-P., Federoff, H. J., & Brownlee, M. (1995) · Molecular Medicine · doi:10.1007/bf03401589 · Cited by 246
Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.012 · Cited by 244
Harhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., & Antonetti, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0322 · Cited by 238
Zheng, L., Szabó, C., & Kern, T. S. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2960 · Cited by 238
Self-citationMolecular basis for a link between complement and the vascular complications of diabetes
Acosta, J., Hettinga, J., Flückiger, R., Krumrei, N., Goldfine, A., Angarita, L., & Halperin, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5450 · Cited by 232
Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease
Ishida, S., Yamashiro, K., Usui, T., Kaji, Y., Ogura, Y., Hida, T., Honda, Y., Oguchi, Y., & Adamis, A. P. (2003) · Nature Medicine · doi:10.1038/nm877 · Cited by 229
Role of interleukin-1 in the pathogenesis of diabetic retinopathy
Kowluru, R. A. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.038133 · Cited by 228
A Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110050024 · Cited by 228
Kowluru, R. A., & Odenbach, S. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3233 · Cited by 227
Molecular Mechanisms of Vascular Permeability in Diabetic Retinopathy
Antonetti, D. A., Lieth, E., Barber, A. J., & Gardner, T. W. (1999) · Seminars in Ophthalmology · doi:10.3109/08820539909069543 · Cited by 225
Zheng, L., Du, Y., Miller, C., Gubitosi-Klug, R. A., Kern, T. S., Ball, S., & Berkowitz, B. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0734-9 · Cited by 224
Self-citationEarly Retinal Damage in Experimental Diabetes: Electroretinographical and Morphological Observations
Li, Q., Zemel, E., Miller, B., & Perlman, I. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1170 · Cited by 220
Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine
Du, Y., Smith, M. A., Miller, C. M., & Kern, T. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00737.x · Cited by 219
Self-citationVEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 217
Joussen, A. M., Poulaki, V., Mitsiades, N., Cai, W., Suzuma, I., Pak, J., Ju, S., Rook, S. L., Esser, P., Mitsiades, C., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0157fje · Cited by 209
Neuroprotection by tetracyclines
Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205
El-Remessy, A. B., Behzadian, M. A., Abou-Mohamed, G., Franklin, T., Caldwell, R. W., & Caldwell, R. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64332-5 · Cited by 203
The RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
Suppression of Diabetic Retinopathy with Angiopoietin-1
Joussen, A. M., Poulaki, V., Tsujikawa, A., Qin, W., Qaum, T., Xu, Q., Moromizato, Y., Bursell, S.-E., Wiegand¶, S. J., Rudge, J., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61115-7 · Cited by 198
Minocycline for Short‐Term Neuroprotection
Elewa, H. F., Hilali, H., Hess, D. C., Machado, L. S., & Fagan, S. C. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.4.515 · Cited by 196
Retinal glutamate in diabetes and effect of antioxidants
Kowluru, R. A., Engerman, R. L., Case, G. L., & Kern, T. S. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00112-1 · Cited by 195
Self-citationCaspase Activation in Retinas of Diabetic and Galactosemic Mice and Diabetic Patients
Mohr, S., Xi, X., Tang, J., & Kern, T. S. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1172 · Cited by 195
Self-citationOxidative stress, transcription factors and chromatin remodelling in lung inflammation
Rahman, I. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01153-x · Cited by 194
Aiello, L. P., Bursell, S. E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.9.1473 · Cited by 194
Seki, M., Tanaka, T., Nawa, H., Usui, T., Fukuchi, T., Ikeda, K., Abe, H., & Takei, N. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2412 · Cited by 193
Delivery of Gentamicin to the Rabbit Eye by Drug-Loaded Hydrogel Iontophoresis
Eljarrat-Binstock, E., Raiskup, F., Stepensky, D., Domb, A. J., & Frucht-Pery, J. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1294 · Cited by 192
Oscillatory Potential Analysis and ERGs of Normal and Diabetic Rats
Hancock, H. A., & Kraft, T. W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1080 · Cited by 189
Minocycline inhibits LPS-induced retinal microglia activation
WANG, A., YU, A., LAU, L., LEE, C., WU, L., ZHU, X., & TSO, M. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.018 · Cited by 178
Kern, T. S., Miller, C. M., Du, Y., Zheng, L., Mohr, S., Ball, S. L., Kim, M., Jamison, J. A., & Bingaman, D. P. (2007) · Diabetes · doi:10.2337/db05-1621 · Cited by 177
Self-citationSalicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 176
Self-citationThe Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Moore, T. C. B., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B., et al. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1063 · Cited by 172
Ramana, K. V., Friedrich, B., Srivastava, S., Bhatnagar, A., & Srivastava, S. K. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2910 · Cited by 170
Du, Y., Sarthy, V. P., & Kern, T. S. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00080.2003 · Cited by 169
Self-citation(2006) · PubMed · Cited by 166
Glycation Inactivation of the Complement Regulatory Protein CD59
Qin, X., Goldfine, A., Krumrei, N., Grubissich, L., Acosta, J., Chorev, M., Hays, A. P., & Halperin, J. A. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2653 · Cited by 166
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164
The Damad Study Group (1989) · Diabetes · doi:10.2337/diabetes.38.4.491 · Cited by 163
Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton, R. G., Chang, K. C., LeJeune, W. S., et al. (1999) · PubMed · Cited by 161
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG, E. W. M., & ADAMIS, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161
Mason, J. O., Nixon, P. A., & WHITE, M. F. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.04.058 · Cited by 154
Characterization of Retinal Leukostasis and Hemodynamics in Insulin Resistance and Diabetes
Abiko, T., Abiko, A., Clermont, A. C., Shoelson, B., Horio, N., Takahashi, J., Adamis, A. P., King, G. L., & Bursell, S. (2003) · Diabetes · doi:10.2337/diabetes.52.3.829 · Cited by 154
Ayalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 152
Inhibition of nitric oxide formation by guanidines
Hasan, K., Heesen, B., Corbett, J. A., McDaniel, M. L., Chang, K. C., Allison, W., Wolffenbuttel, B. H. R., Williamson, J. R., & Tilton, R. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90667-7 · Cited by 151
Zhang, J., Gerhardinger, C., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3499 · Cited by 149
Pi, R., Li, W., Lee, N. T. K., Chan, H. H. N., Pu, Y., Chan, L. N., Sucher, N. J., Chang, D. C., Li, M., & Han, Y. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02796.x · Cited by 146
Effects of Aspirin Treatment on Diabetic Retionopathy
* (1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38010-5 · Cited by 144
Sone, H., Kawakami, Y., Okuda, Y., Sekine, Y., Honmura, S., Matsuo, K.-I., Segawa, T., Suzuki, H., & Yamashita, K. (1997) · Diabetologia · doi:10.1007/s001250050740 · Cited by 138
Aizu, Y., Oyanagi, K., Hu, J., & Nakagawa, H. (2002) · Neuropathology · doi:10.1046/j.1440-1789.2002.00439.x · Cited by 138
Microglial changes occur without neural cell death in diabetic retinopathy
Gaucher, D., Chiappore, J.-A., Pâques, M., Simonutti, M., Boîtard, C., Sahel, J., Massin, P., & Picaud, S. A. (2006) · Vision Research · doi:10.1016/j.visres.2006.11.017 · Cited by 134
Wilkinson‐Berka, J. L. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383142 · Cited by 133
Increased Prevalence of Microthromboses in Retinal Capillaries of Diabetic Individuals
Boeri, D., Maiello, M., & Lorenzi, M. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1432 · Cited by 130
Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C., & Lorenzi, M. (2006) · Diabetes · doi:10.2337/db06-0138 · Cited by 129
Hammes, H. P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S., & Federlin, K. (1994) · Diabetologia · doi:10.1007/bf00428774 · Cited by 128
Yu, P. H., & Zuo, D. (1997) · Diabetologia · doi:10.1007/s001250050816 · Cited by 126
El-Asrar, A. M. A., Desmet, S., Meersschaert, A., Dralands, L., Missotten, L., & Geboes, K. J. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01127-8 · Cited by 123
Tammali, R., Ramana, K. V., Singhal, S. S., Awasthi, S., & Sk, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2105 · Cited by 120
Antioxidants, Redox-Regulated Transcription Factors, and Inflammation
Winyard, P. G., & Blake, D. R. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60993-x · Cited by 118
Gu, L., Hagiwara, S., Fan, Q., Tanimoto, M., Kobata, M., Yamashita, M., Nishitani, T., Gohda, T., Ni, Z., Qian, J., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi210 · Cited by 116
Ou, P., & Wolff, S. P. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90461-5 · Cited by 115
Neuroprotection in Huntington??s disease: a 2-year study on minocycline
Bonelli, R. M., dl, A. K. H., Hofmann, P., & Kapfhammer, H. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200411000-00004 · Cited by 111
Felinski, E. A., & Antonetti, D. A. (2005) · Current Eye Research · doi:10.1080/02713680500263598 · Cited by 110
Lai, A. Y., & Todd, K. G. (2006) · Glia · doi:10.1002/glia.20335 · Cited by 108
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema: A Prospective, Randomized Study
Jonas, J. B., Kamppeter, B. A., Harder, B., Vossmerbaeumer, U., Sauder, G., & Spandau, U. H. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.200 · Cited by 108
González‐Clemente, J. M., Mauricio, D., Richart, C., Broch, M., Caixàs, A., Megía, A., Giménez‐Palop, O., Simón, I., Martínez-Riquelme, A., Giménez‐Pérez, G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02376.x · Cited by 103
Ramana, K. V., Willis, M. S., White, M., Horton, J. W., DiMaio, J. M., Srivastava, D., Bhatnagar, A., & Sk, S. (2006) · Circulation · doi:10.1161/circulationaha.106.630830 · Cited by 102
Alves, M., Calegari, V. C., Cunha, D. A., Saad, M. J. A., Velloso, L. A., & Rocha, E. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0010-9 · Cited by 92
do Carmo, A., Cunha-Vaz, J. G., Carvalho, A. P., & Lopes, M. C. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0312 · Cited by 89
Kowluru, R. A., Engerman, R. L., & Kern, T. S. (2000) · Current Eye Research · doi:10.1076/ceyr.21.4.814.5545 · Cited by 88
Self-citationAntioxidant treatment of experimental diabetic retinopathy in rats with nicanartine
Hammes, H., Bartmann, A., Engel, L., & Wülfroth, P. (1997) · Diabetologia · doi:10.1007/s001250050726 · Cited by 87
Ramana, K. V., Bhatnagar, A., & Sk, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1650com · Cited by 85
Effects of minocycline alone and in combination with mild hypothermia in embolic stroke
Wang, C. X., Yang, T., & Shuaib, A. M. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04045-3 · Cited by 83
Mamputu, J., & Renier, G. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603265 · Cited by 81
Chen, W., Jump, D. Β., Grant, M. B., Esselman, W. J., & Busik, J. V. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0418 · Cited by 80
Starita, C., Patel, M., Katz, B., & Adamis, A. P. (2007) · KARGER eBooks · doi:10.1159/000098504 · Cited by 73
Takeda, M., Mori, F., Yoshida, A., Takamiya, A., Nakagomi, S., Sato, E., & Kiyama, H. (2001) · Diabetologia · doi:10.1007/s001250100588 · Cited by 72
Intravitreal Triamcinolone Acetonide for Diabetic Retinopathy
Jonas, J. B. (2007) · KARGER eBooks · doi:10.1159/000098502 · Cited by 71
Xu, X., Zhu, Q., Xia, X., et al. (2004) · Current Eye Research · doi:10.1076/ceyr.28.4.251.27834 · Cited by 71
Berkowitz, B. A., Roberts, R., Luan, H., Peysakhov, J., Mao, X., & Thomas, K. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1381 · Cited by 66
Sun, W., Gerhardinger, C., Dagher, Z., Hoehn, T., & Lorenzi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3418 · Cited by 63
do Carmo, A., Lopes, C., Santos, M. S., Proença, R. D., Cunha-Vaz, J. G., & Carvalho, A. P. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00363-7 · Cited by 62
Muranaka, K., Yanagi, Y., Tamaki, Y., Usui, T., Kubota, N., Iriyama, A., Terauchi, Y., Kadowaki, T., & Araie, M. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1432 · Cited by 61
Segawa, Y., Shirao, Y., Yamagishi, S., Higashide, T., Kobayashi, M., Katsuno, K., Iyobe, A., Harada, H., Sato, F., Miyata, H., et al. (1998) · Ophthalmic Research · doi:10.1159/000055493 · Cited by 60
Ayalasomayajula, S. P., Amrite, A. C., & Kompella, U. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.046 · Cited by 56
Haslbeck, K.-M., Bierhaus, A., Erwin, S., Kirchner, A., Nawroth, P. P., Schlötzer, U., Neundörfer, B., & Heuß, D. F. (2004) · Muscle & Nerve · doi:10.1002/mus.20039 · Cited by 56
Baptiste, D. C., Hartwick, A. T. E., Jollimore, C. A. B., Baldridge, W. H., Seigel, G. M., & Kelly, M. E. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001081 · Cited by 55
Clinical trials of neuroprotection for Parkinson’s disease
LeWitt, P. A. (2004) · Neurology · doi:10.1212/wnl.63.7_suppl_2.s23 · Cited by 54
Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature
Johnson, E. I. M., Dunlop, M., & Larkins, R. G. (1999) · Current Eye Research · doi:10.1076/ceyr.18.2.79.5386 · Cited by 51
Harada, C., Okumura, A., Namekata, K., Nakamura, K., Mitamura, Y., Ohguro, H., & Harada, T. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.017 · Cited by 46
Zoppini, G., Faccini, G., Muggeo, M., Zenari, L., Falezza, G., & Targher, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7786 · Cited by 46
The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat
Kamijo, M., Cherian, P., & Sima, A. A. F. (1993) · Diabetologia · doi:10.1007/bf02374469 · Cited by 44
Arauz-Pacheco, C., Ramirez, L. C., Pruneda, L., Sanborn, G. E., Rosenstock, J., & Raskin, P. (1992) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(92)90024-f · Cited by 43
Harris, A. G., Skalak, T. C., & Hatchell, D. L. (2008) · International Journal of Microcirculation · doi:10.1159/000178824 · Cited by 42
Oxidants, Transcription Factors, and Intestinal Inflammation
Jourd’heuil, D., Morise, Z., Conner, E. M., & Grisham, M. B. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199700001-00011 · Cited by 41
Mori, F. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.10.1172 · Cited by 41
Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects
Davies, C. S., Harris, C. L., & Morgan, B. P. (2005) · Immunology · doi:10.1111/j.1365-2567.2004.02086.x · Cited by 39
Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes
Agardh, E., Bruun, A., & Agardh, C. (2001) · Current Eye Research · doi:10.1076/ceyr.23.4.276.5459 · Cited by 39
The role of transcription factors in allergic inflammation
Escoubet‐Lozach, L., Glass, C. K., & Wasserman, S. I. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.128076 · Cited by 38
Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina
Park, J., Park, S. J., Park, S.-H., Keun-young Kim, A., Chung, J.-W., Chun, M., & Oh, S.-J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.007 · Cited by 35
Retinal metabolic abnormalities in diabetic mouse: Comparison with diabetic rat
Kowluru, R. A. (2002) · Current Eye Research · doi:10.1076/ceyr.24.2.123.8158 · Cited by 34
Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina
Steinle, J. J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.006 · Cited by 33
Early Effects of Intravitreal Triamcinolone on Macular Edema
Miyamoto, N., Iossifov, D., Metge, F., & Béhar‐Cohen, F. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.037 · Cited by 33
Kinoshita, N., Kakehashi, A., Inoda, S., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0820-y · Cited by 33
Arachidonic acid metabolism by retinas of rats with streptozotocin-induced diabetes
Naveh-Floman, N., Weissman, C. R., & Belkin, M. (1984) · Current Eye Research · doi:10.3109/02713688409000813 · Cited by 32
Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice
Tadayoni, R., Pâques, M., Gaudric, A., & Vicaut, É. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00155-6 · Cited by 31
Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Kojima, K., Matsubara, H., Harada, T., et al. (1985) · PubMed · Cited by 28
Musashi, K., Kiryu, J., Miyamoto, K., Miyahara, S., Katsuta, H., Tamura, H., Hirose, F., & Yoshimura, N. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1102 · Cited by 22
Revisiting safety of minocycline as neuroprotection in Huntington's disease
Reynolds, N. C. (2006) · Movement Disorders · doi:10.1002/mds.21199 · Cited by 21
[The expression of HIF-1 in the early diabetic NOD mice].
Li, C., Xu, Y., Jiang, D., Hong, W., Guo, X.-J., Wang, P., & Li, W. (2006) · PubMed · Cited by 9
Cited by
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Self-citationRole of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
(2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.015 · Cited by 548
Metadata
- Authors
- Kern, T. S.
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 2007
- Issue
- 1
- Pages
- 95103-95103
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2060141430
- Cited by
- 614
- References
- 164
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.